Title |
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
|
---|---|
Published in |
Cochrane database of systematic reviews, November 2013
|
DOI | 10.1002/14651858.cd002309.pub4 |
Pubmed ID | |
Authors |
Chong, Jimmy, Leung, Bonnie, Poole, Phillippa |
Abstract |
Chronic obstructive pulmonary disease (COPD) is associated with cough, sputum production or dyspnoea and a reduction in lung function, quality of life and life expectancy. Apart from smoking cessation, there are no other treatments that slow lung function decline. Roflumilast and cilomilast are oral phosphodiesterase 4 (PDE4) inhibitors proposed to reduce the airway inflammation and bronchoconstriction seen in COPD. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 20% |
Spain | 1 | 20% |
Unknown | 3 | 60% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 80% |
Science communicators (journalists, bloggers, editors) | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 165 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
United States | 1 | <1% |
Italy | 1 | <1% |
Unknown | 162 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 39 | 24% |
Researcher | 27 | 16% |
Student > Bachelor | 14 | 8% |
Student > Postgraduate | 13 | 8% |
Other | 11 | 7% |
Other | 28 | 17% |
Unknown | 33 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 58 | 35% |
Psychology | 22 | 13% |
Nursing and Health Professions | 12 | 7% |
Social Sciences | 10 | 6% |
Engineering | 4 | 2% |
Other | 17 | 10% |
Unknown | 42 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 July 2017.
All research outputs
#2,579,731
of 25,806,763 outputs
Outputs from Cochrane database of systematic reviews
#5,148
of 13,140 outputs
Outputs of similar age
#23,363
of 229,005 outputs
Outputs of similar age from Cochrane database of systematic reviews
#109
of 247 outputs
Altmetric has tracked 25,806,763 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 229,005 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 247 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.